戻る
BioDlink International Company Limited (01875.HK)価格
01875.HK 株価推移チャート
BIODLINK-B (01875.HK)
BioDlink International Company Limited
HK$4.26
-5.33%
$-0.24
休場: Jan 16, 16:00:00 HKT
データなしEarnings FAQ
01875.HKの最近の1株当たり利益（EPS）は予想と比較してどうでしたか？
BioDlink International Company Limited 01875.HKの前四半期の収益はどうでしたか？
BioDlink International Company Limitedの収益見積もりはいくらですか？
BioDlink International Company Limitedの収益品質スコアはどれくらいですか？
BioDlink International Company Limitedはいつ収益を報告しますか？
BioDlink International Company Limitedの予想収益はいくらですか？
BioDlink International Company Limitedは収益予想を上回りましたか？
主要データ
前終値
$4.19
始値
$4.5
当日レンジ
$4.21 - $4.66
52週レンジ
$1.52 - $4.26
取引高
35.2M
平均取引高
141.4K
1株当たり利益(TTM)
0.02
配当利回り
--
時価総額
$3.0B
BIODLINK-Bとは何ですか？
BioDlink International Co., Ltd. is clinical stage biopharmaceutical company, which engages in developing and commercializing oncology drugs and therapies. The company is headquartered in Suzhou, Jiangsu and currently employs 604 full-time employees. The company went IPO on 2019-11-08. The firm and its subsidiaries are primarily engaged in research, development, manufacturing, and marketing of anti-tumor drugs, contract development and manufacturing organization (CDMO) business and license-out of self-developed biological drugs in the People’s Republic of China. The firm owns a pipeline of oncology drug candidates, which include monoclonal antibodies (mAbs) and antibody-drug conjugates (ADCs). The firm has built and established a fully integrated in-house platform of discovery, process development, quality management, pre-clinical and clinical development, as well as commercial-scale manufacturing facilities and sales and marketing capabilities. The firm mainly conducts its businesses in the domestic market.